Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

October 6, 2025

Study Completion Date

December 6, 2025

Conditions
Breast CancerLung CancerGastrointestinal CancerMultiple Myeloma
Interventions
OTHER

survey

Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic PRO surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks.

Trial Locations (1)

44131

Cleveland Clinic, Cleveland

Sponsors
All Listed Sponsors
lead

Carevive Systems, Inc.

INDUSTRY